# rhTNK-tPA Thrombolytic Removal of Intraventricular Hemorrhage

> **NCT06814964** · PHASE1 · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Intraventricular Hemorrhage

## Interventions

- **DRUG:** Low dose group
- **DRUG:** Medium dose group
- **DRUG:** High dose group

## Key facts

- **NCT ID:** NCT06814964
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06814964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06814964, "rhTNK-tPA Thrombolytic Removal of Intraventricular Hemorrhage". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06814964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*